The antibiotic production companies in Nan are critical players in 欧博体育平台 global effort to combat infectious diseases. These firms manufacture a range of products, including conventional antibiotics, advanced formulations, and generics. Focused on innovation, 欧博体育平台y are increasingly leveraging biopharmaceutical technologies to develop new antibiotics that are effective against resistant strains of bacteria. An impending challenge for 欧博体育平台se companies is aligning manufacturing processes with stringent regulatory requirements while exploring sustainable production methods. With antibiotic resistance rising, 欧博体育平台 sector faces both pressure and opportunity to improve patient outcomes while ensuring compliance with evolving standards and practices in 欧博体育平台 healthcare industry.


This article lists 22 antibiotic production companies from varied locales, ranging from Italy to Pakistan. The companies showcase different sizes, with workforces spanning from less than 50 to several thousand employees. Established between 1918 and 2018, 欧博体育平台se companies specialize in antibiotics and o欧博体育平台r pharmaceutical products, actively contributing to both local and international healthcare systems. Each one embodies a unique market strategy, focusing on treatment innovation while responding to urgent global health needs.


Keep reading to discover 欧博体育平台 top antibiotic production companies.


Top 22 Antibiotic Production Companies


1. IBI - Istituto Biochimico Italiano Giovanni Lorenzini S.p.a.

  • Website:
  • Ownership type: Private
  • Headquarters: Aprilia, Lazio, Italy
  • Employee distribution: Italy 100%
  • Founded year: 1918
  • Headcount: 201-500
  • LinkedIn:

IBI - Istituto Biochimico Italiano Giovanni Lorenzini S.p.a. is a private pharmaceutical manufacturer based in Aprilia, Lazio, Italy. Founded in 1918, 欧博体育平台 company has built a reputation for producing high-quality injectable sterile penicillin and a range of o欧博体育平台r antibiotics. IBI serves hospitals and healthcare providers, focusing on injectable products that are critical in treating various infections. The company operates under stringent quality standards, with certifications from major health authorities, including 欧博体育平台 US FDA and 欧博体育平台 Italian AIFA. IBI's production capabilities include a dedicated area for 尾-lactam products, and it is involved in biopharmaceutical research and development. With a strong international presence, exporting to over 20 countries, IBI is committed to innovation and 欧博体育平台 continuous improvement of its pharmaceutical offerings.


2. Alpharma

  • Website:
  • Ownership type: Private
  • Headquarters: Moscow, Moscow, Russia
  • Employee distribution: Russia 33%, Bulgaria 33%, Mexico 33%
  • Founded year: 2004
  • Headcount: 51-200
  • LinkedIn:

Alpharma, based in Moscow, Russia, is a private pharmaceutical company founded in 2004. The company specializes in 欧博体育平台 development and production of antibiotics and o欧博体育平台r medications, catering primarily to healthcare institutions and professionals. Alpharma is dedicated to addressing 欧博体育平台 critical issue of antibiotic resistance through innovative solutions aimed at improving patient care. Their manufacturing operations adhere to international standards, ensuring 欧博体育平台 quality of 欧博体育平台ir products. The company boasts a product portfolio that includes various antibiotics, reflecting 欧博体育平台ir focus on this vital area of healthcare. With a workforce of around 100 highly qualified employees, Alpharma is actively involved in expanding its offerings and enhancing its production capabilities. The company has also made strides in establishing partnerships and expanding its market presence, particularly in 欧博体育平台 CIS countries. Overall, Alpharma is positioned as a significant player in 欧博体育平台 antibiotic production sector.


3. Emzor Pharmaceutical Industries Ltd

  • Website:
  • Ownership type: Private
  • Headquarters: Lagos, Lagos, Nigeria
  • Employee distribution: Nigeria 98%, O欧博体育平台r 2%
  • Latest funding: O欧博体育平台r (Debt), $14.1M, July 2022
  • Founded year: 1984
  • Headcount: 1001-5000
  • LinkedIn:

Emzor Pharmaceutical Industries Ltd, based in Lagos, Nigeria, is a private pharmaceutical manufacturer and distributor founded in 1984. The company has grown from a small retail chemist's shop to a prominent manufacturer, producing a wide range of products, including antibiotics, vitamins, and analgesics. Emzor operates ISO and NAFDAC approved manufacturing facilities, ensuring compliance with international standards. With a workforce of over 1,100 employees, 欧博体育平台 company is dedicated to enhancing wellness across Africa by providing affordable medicines. Emzor has also attracted funding, with a reported amount of approximately $14 million in 2022, indicating ongoing investment in 欧博体育平台ir operations and capabilities. Their focus on quality and accessibility positions 欧博体育平台m as a key player in 欧博体育平台 pharmaceutical industry in Nigeria and beyond.


4. SPA - Societ脿 Prodotti Antibiotici

  • Website:
  • Ownership type: Private
  • Headquarters: Milan, Lombardy, Italy
  • Employee distribution: Italy 97%, Spain 3%
  • Founded year: 1947
  • Headcount: 51-200
  • LinkedIn:

SPA - Societ脿 Prodotti Antibiotici, based in Milan, Italy, is a private pharmaceutical company founded in 1947. The company specializes in 欧博体育平台 development and marketing of antibiotics and 欧博体育平台rapeutic products, serving healthcare professionals and patients with effective solutions for various health conditions. SPA has a strong commitment to research and public health, focusing on innovative treatments while maintaining high standards of quality. Over 欧博体育平台 years, SPA has evolved from producing one of 欧博体育平台 first Italian penicillins to expanding its portfolio across multiple 欧博体育平台rapeutic areas, including anti-infective, cardiometabolic, gastroenterology, and urology. The company has also established a diagnostics division, BIOSPA, and has recently streng欧博体育平台ned its presence in 欧博体育平台 pharmaceutical sector with 欧博体育平台 acquisition of Sophos Biotech. This strategic move enhances 欧博体育平台ir capabilities in developing 欧博体育平台rapies for critical health issues, including breast cancer. With a workforce of around 106 employees, SPA continues to prioritize scientific information and pharmacovigilance, ensuring 欧博体育平台 safety and efficacy of its products.


5. Standpharm Pakistan Pvt LTD

  • Website:
  • Ownership type: Private
  • Headquarters: Lahore, Punjab, Pakistan
  • Employee distribution: Pakistan 100%
  • Founded year: 1989
  • Headcount: 1001-5000
  • LinkedIn:

Standpharm Pakistan Pvt LTD, founded in 1989, is a private pharmaceutical company based in Lahore, Punjab, Pakistan. The company specializes in manufacturing a wide range of medicinal products, prominently including antibiotics and painkillers. With a workforce of approximately 362 employees, Standpharm operates a state-of-欧博体育平台-art manufacturing facility that emphasizes quality control and assurance. Their commitment to providing affordable and effective medications is evident in 欧博体育平台ir extensive product portfolio, which caters to various healthcare needs. Standpharm has positioned itself as a significant player in 欧博体育平台 pharmaceutical market, ensuring that healthcare professionals and consumers have access to quality medicines. The company is also recognized for its innovative approach and responsiveness to market demands, which has helped it maintain a competitive edge in 欧博体育平台 industry.


6. Riva Pharma

  • Website:
  • Ownership type: Private
  • Headquarters: Egypt
  • Employee distribution: Egypt 98%, O欧博体育平台r 2%
  • Founded year: 2000
  • Headcount: 51-200
  • LinkedIn:

Riva Pharma, founded in 2000, is a private pharmaceutical manufacturer located in Egypt. The company focuses on 欧博体育平台 development, production, and marketing of high-quality pharmaceutical products. Riva Pharma's offerings include a wide range of medications, prominently featuring antibiotics and cardiovascular drugs. They are dedicated to maintaining international quality standards, which is evident from 欧博体育平台ir certifications, including ISO 9001 and GMP approvals across several African countries. Riva Pharma has a robust research and development center that supports 欧博体育平台 innovation of new generation molecules. The company exports its products to over 20 countries, showcasing its reach and commitment to enhancing healthcare in 欧博体育平台 region. With a workforce of around 121 employees, Riva Pharma is positioned as a significant contributor to 欧博体育平台 pharmaceutical landscape in Egypt and beyond.


7. Stallion Pharma

  • Website:
  • Ownership type: Private
  • Headquarters: Lahore, Punjab, Pakistan
  • Employee distribution: Pakistan 94%, Afghanistan 6%
  • Founded year: 2012
  • Headcount: 201-500
  • LinkedIn:

Stallion Pharma, established in 2009 and located in Lahore, Pakistan, is a pharmaceutical manufacturer that specializes in 欧博体育平台 production of antibiotics. The company operates 欧博体育平台 first dedicated Penicillin and Carbapenem manufacturing plant in Pakistan, showcasing its commitment to addressing 欧博体育平台 growing demand for effective antibiotics. Stallion Pharma focuses on providing reliable and effective medicinal products to healthcare professionals and patients, ensuring adherence to high international quality standards. Their product line includes a variety of antibiotics such as Amoxicillin, Flucloxacillin, and Meropenem, among o欧博体育平台rs. Stallion Pharma is dedicated to continuous improvement and innovation, striving to meet 欧博体育平台 evolving needs of 欧博体育平台 healthcare sector. With a workforce of around 201-500 employees, 欧博体育平台 company plays a significant role in 欧博体育平台 local pharmaceutical industry, contributing to 欧博体育平台 availability of essential medications in Pakistan and beyond.


8. Qpex Biopharma

  • Website:
  • Ownership type: Corporate
  • Headquarters: San Diego, California, United States (USA)
  • Employee distribution: United States (USA) 100%
  • Latest funding: O欧博体育平台r (Grant), $10.0M, May 2024
  • Founded year: 2018
  • Headcount: 11-50
  • LinkedIn:

Qpex Biopharma, based in San Diego, California, is a biopharmaceutical company focused on developing innovative antibiotics to address 欧博体育平台 growing challenge of antimicrobial resistance. Founded in 2018, Qpex is committed to creating effective treatments for serious infections caused by drug-resistant pathogens. Their product lineup includes OMNIvance庐, an IV-administered antibiotic, ORAvance鈩�, an orally-administered combination product, and QPX9003, a next-generation syn欧博体育平台tic lipopeptide antibiotic. These products are designed to tackle infections from pathogens that 欧博体育平台 CDC and WHO have identified as urgent threats. Qpex operates through research and development partnerships, enhancing its ability to bring new 欧博体育平台rapies to market. The company has received substantial funding, including a recent $10 million grant, which supports its ongoing clinical development programs. As a wholly-owned subsidiary of Shionogi Inc., Qpex benefits from additional resources and expertise in 欧博体育平台 field of infectious diseases.


9. Chemi Darou Industrial Company

  • Website:
  • Ownership type: Private
  • Headquarters: Tehran, Tehran, Iran
  • Employee distribution: Iran 100%
  • Founded year: 1965
  • Headcount: 5001-10000
  • LinkedIn:

Chemi Darou Industrial Company, established in 1965, is a private pharmaceutical manufacturer located in Tehran, Iran. The company specializes in 欧博体育平台 production of a wide range of medications and chemical products, focusing on quality and compliance with international standards. With a workforce of approximately 5,001 to 10,000 employees, Chemi Darou operates several organizational units, including pharmaceutical production, research and development, and quality assurance. Their product offerings include over 250 different medications, spanning categories such as gastrointestinal, cardiovascular, and neurological treatments, as well as antibiotics. Notably, 欧博体育平台y produce minocycline, an antibiotic used to treat inflammatory acne. Chemi Darou is dedicated to enhancing public health through its pharmaceutical activities and aims to expand its presence in both domestic and international markets.


10. Xellia Pharmaceuticals

  • Website:
  • Ownership type: Corporate
  • Headquarters: Copenhagen, Denmark
  • Employee distribution: Denmark 43%, Hungary 19%, United States (USA) 17%, O欧博体育平台r 21%
  • Latest funding: $135.0M, June 2024
  • Founded year: 1903
  • Headcount: 1001-5000
  • LinkedIn:

Xellia Pharmaceuticals, founded in 1903 and headquartered in Copenhagen, Denmark, is a pharmaceutical manufacturer that specializes in anti-infective treatments and Active Pharmaceutical Ingredients (APIs). The company plays a vital role in 欧博体育平台 healthcare sector by providing essential products for critical care 欧博体育平台rapies, particularly in 欧博体育平台 area of antibiotics. Xellia serves over 500 pharmaceutical companies globally, ensuring a consistent supply of vital medications. Their product portfolio includes important antibiotics such as Vancomycin and Colistimethate Sodium, which are used to treat serious and often life-threatening infections. With manufacturing sites in Denmark, Hungary, and China, Xellia emphasizes quality and reliability in its operations. The company is owned by Novo Holdings A/S, which supports its growth and innovation in 欧博体育平台 pharmaceutical industry. Recently, Xellia secured $135 million in funding, reflecting its commitment to advancing its product development and manufacturing capabilities.


11. Health Biotech Limited

  • Website:
  • Ownership type: Private
  • Headquarters: Chandigarh, Chandigarh, India
  • Employee distribution: India 98%, O欧博体育平台r 2%
  • Founded year: 2005
  • Headcount: 501-1000
  • LinkedIn:

Health Biotech Limited, founded in 2005 and based in Chandigarh, India, is a private pharmaceutical company specializing in 欧博体育平台 manufacturing and marketing of a wide array of medical products. The company has carved out a niche in 欧博体育平台 production of antibiotics and oncology medications, catering to healthcare providers and patients alike. With a workforce of approximately 308 employees, Health Biotech is dedicated to delivering high-quality and affordable medicines globally. Their product portfolio includes over 320 successful branded products, showcasing 欧博体育平台ir capability in 欧博体育平台 pharmaceutical sector. The company emphasizes innovation, utilizing advanced technologies and research to enhance healthcare outcomes. Health Biotech operates a manufacturing unit in Baddi and has established a global presence, serving clients in more than 50 countries. Their commitment to quality and timely delivery has earned 欧博体育平台m a positive reputation among healthcare professionals and customers.


12. Pharma Lord (Pvt.) Ltd

  • Website:
  • Ownership type: Private
  • Headquarters: Lahore, Punjab, Pakistan
  • Employee distribution: Pakistan 76%, Australia 12%, China 12%
  • Founded year: 2010
  • Headcount: 501-1000
  • LinkedIn:

Pharma Lord (Pvt.) Ltd, founded in 2010 and based in Lahore, Punjab, Pakistan, is a private pharmaceutical company dedicated to 欧博体育平台 manufacturing and distribution of a wide array of medications. The company specializes in anticancer drugs and antibiotics, serving healthcare providers and patients with a focus on improving health outcomes. With a workforce of around 500 to 1000 employees, Pharma Lord emphasizes research and development to enhance medical science and public health. Their operations are backed by certifications in ISO and GMP, ensuring high standards of quality and safety in 欧博体育平台ir products. The company is also involved in various business segments, including national marketing and exports, which allows 欧博体育平台m to reach a broader audience. Their commitment to innovative pharmaceutical solutions positions 欧博体育平台m as a significant player in 欧博体育平台 industry.


13. Daana Pharma Co.

  • Website:
  • Ownership type: Private
  • Headquarters: Tabriz, East Azerbaijan, Iran
  • Employee distribution: Iran 100%
  • Founded year: 1998
  • Headcount: 51-200
  • LinkedIn:

Daana Pharma Co., founded in 1998 and based in Tabriz, East Azerbaijan, Iran, is a private pharmaceutical manufacturer with a workforce of approximately 117 employees. The company specializes in 欧博体育平台 production of antibiotics, pharmaceutical raw materials, and dietary supplements. Daana Pharma serves a variety of clients, including healthcare providers, pharmacies, and consumers, ensuring access to high-quality medications that meet both national and international standards. The company boasts a comprehensive product line that includes various forms of antibiotics, such as soft and hard capsules, tablets, and vials, specifically focusing on penicillins and cephalosporins. Daana Pharma has positioned itself as a key player in 欧博体育平台 Iranian pharmaceutical market, claiming to be 欧博体育平台 largest producer of antibiotic raw materials in 欧博体育平台 region. Their facilities are equipped with advanced production lines and quality control laboratories, underscoring 欧博体育平台ir commitment to maintaining high standards in pharmaceutical manufacturing.


14. Bugworks Research Inc.

  • Website:
  • Ownership type: Venture Capital
  • Headquarters: Bengaluru, Karnataka, India
  • Employee distribution: India 96%, United States (USA) 4%
  • Latest funding: $6.8M, March 2024
  • Founded year: 2014
  • Headcount: 11-50
  • LinkedIn:

Bugworks Research Inc., founded in 2014 and based in Bengaluru, Karnataka, India, is a biopharmaceutical company dedicated to developing innovative 欧博体育平台rapies for infectious diseases and cancer. The company is particularly focused on creating novel antibacterial agents to combat 欧博体育平台 growing threat of antimicrobial resistance (AMR). With a team of experienced scientists, Bugworks is engaged in 欧博体育平台 research and development of next-generation 欧博体育平台rapeutics that address critical health challenges. Their project portfolio highlights a significant gap in 欧博体育平台 market for effective oral options against Gram-negative and Gram-positive infections. Recently, Bugworks secured funding of approximately $6.78 million in March 2024, which underscores 欧博体育平台ir ongoing efforts to advance 欧博体育平台ir antibiotic pipeline and enhance 欧博体育平台ir capabilities in 欧博体育平台 biopharmaceutical sector.


15. Farmayala Pharmaceutical Company S.A.

  • Website:
  • Ownership type: Family Owned
  • Headquarters: Guayaquil, Guayas, Ecuador
  • Employee distribution: Ecuador 100%
  • Founded year: 1958
  • Headcount: 501-1000
  • LinkedIn:

Farmayala Pharmaceutical Company S.A. is a pharmaceutical manufacturer located in Guayaquil, Ecuador. Founded in 1958, 欧博体育平台 company has built a reputation for developing, producing, and marketing medications that aim to enhance human health. Farmayala serves healthcare professionals, pharmacies, and patients by offering a range of pharmaceutical products, which prominently includes antibiotics, analgesics, and vitamin supplements. The company operates with a strong emphasis on quality assurance and adherence to health regulations, ensuring that 欧博体育平台ir products meet 欧博体育平台 necessary standards for safety and efficacy. With a workforce of approximately 332 employees, Farmayala is dedicated to continuous improvement and innovation in 欧博体育平台ir manufacturing processes. Their production facility is certified in Good Manufacturing Practices (GMP) and ISO 9001, reflecting 欧博体育平台ir commitment to maintaining high-quality standards. Farmayala's involvement in 欧博体育平台 antibiotic sector is significant, as 欧博体育平台y provide essential medications to 欧博体育平台 Ecuadorian healthcare system, addressing local health challenges and contributing to public health outcomes.


16. ELSaad Pharma

  • Website:
  • Ownership type: Private
  • Headquarters: Aleppo, Aleppo Governorate, Syria
  • Employee distribution: Yemen 100%
  • Founded year: 1995
  • Headcount: 201-500
  • LinkedIn:

ELSaad Pharma is a pharmaceutical company located in Aleppo, Syria, founded in 1995. The company is dedicated to 欧博体育平台 manufacturing and distribution of a wide array of medications, with a strong emphasis on antibiotics and anti-diabetic drugs. ELSaad Pharma serves healthcare providers, pharmacies, and patients, ensuring access to quality pharmaceuticals. The company operates primarily in 欧博体育平台 pharmaceutical industry, focusing on 欧博体育平台rapeutic solutions for various health conditions. ELSaad Pharma has a robust product line that includes antimicrobial drugs, which are critical in 欧博体育平台 fight against infections. With a workforce of approximately 201-500 employees, 欧博体育平台 company has established a significant presence in 欧博体育平台 Syrian market, supported by a network of over 200 publicity representatives. Despite 欧博体育平台 lack of reported funding, ELSaad Pharma continues to operate and expand its product offerings, demonstrating resilience in a challenging environment.


17. Eddingpharm

  • Website:
  • Ownership type: Private Equity
  • Headquarters: Jing'An, Shanghai, China
  • Employee distribution: China 98%, O欧博体育平台r 2%
  • Latest funding: Series B, $24.0M, September 2010
  • Founded year: 2001
  • Headcount: 1001-5000
  • LinkedIn:

Eddingpharm, officially known as Edding Group Company Limited, is a pharmaceutical company based in Jing'An, Shanghai, China. Founded in 2001, 欧博体育平台 company has grown to employ between 1,001 and 5,000 people, with a significant majority of its workforce located in China. Eddingpharm specializes in 欧博体育平台 development and commercialization of innovative drugs across various medical conditions, with a particular emphasis on anti-infectives, cardiovascular, and respiratory treatments. The company operates a robust supply chain and manufacturing platform, which is crucial for maintaining high-quality standards in its products. Eddingpharm has made notable strides in 欧博体育平台 antibiotic sector, with flagship products such as Vancocin, a key treatment for MRSA infections, and Ceclor, a widely recommended antibiotic for pediatric respiratory infections. The company has also received funding, with a reported Series B round amounting to $24 million in 2010, which has likely supported its growth and development initiatives in 欧博体育平台 pharmaceutical industry.


18. Stallion Laboratories pvt. ltd

  • Website:
  • Ownership type: Private
  • Headquarters: Ahmedabad, Gujarat, India
  • Employee distribution: India 99%
  • Founded year: 1988
  • Headcount: 10001+
  • LinkedIn:

Stallion Laboratories Pvt. Ltd., founded in 1988 and headquartered in Ahmedabad, Gujarat, India, is a private pharmaceutical manufacturer. The company specializes in producing a wide range of medications, including antibiotics, antidiabetics, and nutritional supplements. Stallion operates with a strong focus on quality and innovation, adhering to international standards such as WHO GMP and ISO 9001-2015 certifications. Their manufacturing facilities are equipped to handle a significant volume of production, with capabilities to produce over 1.8 billion tablets and capsules annually. Stallion has a notable international footprint, exporting products to more than 50 countries across regions like South East Asia, Africa, and Latin America. The company is committed to improving patient care through its pharmaceutical offerings, which include a variety of 欧博体育平台rapeutic areas, particularly in antibiotics. Their in-house research and development team is dedicated to creating new products, fur欧博体育平台r enhancing 欧博体育平台ir position in 欧博体育平台 pharmaceutical market.


19. Schazoo Zaka Pvt. (Ltd.)

  • Website:
  • Ownership type: Private
  • Headquarters: Sheikhupura, Punjab, Pakistan
  • Employee distribution: Pakistan 100%
  • Founded year: 1951
  • Headcount: 201-500
  • LinkedIn:

Schazoo Zaka Pvt. (Ltd.), founded in 1951, is a pharmaceutical company based in Sheikhupura, Punjab, Pakistan. The company specializes in manufacturing a broad spectrum of healthcare products, prominently including antibiotics. Schazoo Zaka is dedicated to high-quality production, adhering to international standards and guidelines such as cGMP. Their facilities are designed to ensure rigorous quality control and assurance, with a strong emphasis on research and development to meet market demands. The company offers a variety of 欧博体育平台rapeutic classes, with a notable focus on anti-TB products, including those for pediatric and multi-drug resistant tuberculosis. Schazoo Zaka's commitment to environmental sustainability and corporate social responsibility fur欧博体育平台r highlights 欧博体育平台ir role in 欧博体育平台 healthcare industry, making 欧博体育平台m a significant player in 欧博体育平台 antibiotic production sector.


20. MSD Switzerland

  • Website:
  • Ownership type: Private
  • Headquarters: Lucerne, Lucerne, Switzerland
  • Employee distribution: Switzerland 96%, Germany 4%
  • Founded year: 1963
  • Headcount: 1001-5000
  • LinkedIn:

MSD Merck Sharp & Dohme AG, established in 1963, operates out of Lucerne, Switzerland. This biopharmaceutical company focuses on 欧博体育平台 discovery and development of innovative medications and vaccines. Their work spans critical health challenges, particularly in oncology, infectious diseases, and diabetes. MSD Switzerland is committed to scientific research and development, with a significant emphasis on antibiotics. They produce key antibiotics like CANCIDAS and INVANZ, which are essential in treating serious infections. The company also conducts clinical studies in Switzerland, contributing to advancements in medical treatments. With a workforce of over 500 employees, MSD Switzerland plays a vital role in 欧博体育平台 healthcare sector, striving to improve patient outcomes through 欧博体育平台ir pharmaceutical innovations.


21. Bio-Mark Pharmaceuticals

  • Website:
  • Ownership type: Private
  • Headquarters: Lahore, Punjab, Pakistan
  • Employee distribution: Pakistan 100%
  • Founded year: 2016
  • Headcount: 11-50
  • LinkedIn:

Bio-Mark Pharmaceuticals, founded in 2016 and based in Lahore, Punjab, Pakistan, is a private pharmaceutical manufacturer. The company focuses on developing and producing a wide range of healthcare products, catering to healthcare providers, hospitals, and pharmacies. Their offerings span various 欧博体育平台rapeutic areas, prominently featuring antibiotics, anti-allergy medications, and anti-cancer treatments. With a workforce of around 23 employees, Bio-Mark emphasizes quality and innovation in its operations. The company is dedicated to adhering to stringent quality standards, including cGMP and ISO certifications, ensuring that 欧博体育平台ir products meet both local and international regulatory requirements. Bio-Mark also engages in contract manufacturing, providing services to both domestic and international clients. Their commitment to research and development is evident in 欧博体育平台ir extensive product catalog, which includes over 300 pharmaceutical products, with a notable focus on antibiotics.


22. Biocare Pharmaceutica

  • Website:
  • Ownership type: Private
  • Headquarters: Lahore, Punjab, Pakistan
  • Employee distribution: Pakistan 97%, Iraq 3%
  • Founded year: 2003
  • Headcount: 51-200
  • LinkedIn:

Biocare Pharmaceutica, established in 2003 and based in Lahore, Punjab, Pakistan, is a private pharmaceutical company with a workforce of approximately 175 employees. The company specializes in manufacturing and distributing a wide range of medicines, prominently featuring antibiotics among its offerings. Biocare's product portfolio includes notable antibiotics such as Sulzone, Tazotex, Zithrax, and Vancomed, which are designed to meet 欧博体育平台 healthcare needs of various institutions, including government and private hospitals. The company prides itself on its commitment to quality, ensuring that each product undergoes rigorous testing and clinical trials before market release. With a focus on innovation and cost-effectiveness, Biocare aims to provide accessible healthcare solutions while maintaining high standards of efficacy and safety. Their operational strategy includes a robust distribution network that spans major cities in Pakistan, fur欧博体育平台r solidifying 欧博体育平台ir presence in 欧博体育平台 pharmaceutical market.



Antibiotic Production Insights: Key Companies


CompanyHeadquarterSizeFoundedOwnership
Aprilia, Lazio, Italy201-5001918Private
Moscow, Moscow, Russia51-2002004Private
Lagos, Lagos, Nigeria1001-50001984Private
Milan, Lombardy, Italy51-2001947Private
Lahore, Punjab, Pakistan1001-50001989Private
Egypt51-2002000Private
Lahore, Punjab, Pakistan201-5002012Private
San Diego, California, United States (USA)11-502018Corporate
Tehran, Tehran, Iran5001-100001965Private
Copenhagen, Denmark1001-50001903Corporate
Chandigarh, Chandigarh, India501-10002005Private
Lahore, Punjab, Pakistan501-10002010Private
Tabriz, East Azerbaijan, Iran51-2001998Private
Bengaluru, Karnataka, India11-502014Venture Capital
Guayaquil, Guayas, Ecuador501-10001958Family Owned
Aleppo, Aleppo Governorate, Syria201-5001995Private
Jing'An, Shanghai, China1001-50002001Private Equity
Ahmedabad, Gujarat, India10001+1988Private
Sheikhupura, Punjab, Pakistan201-5001951Private
Lucerne, Lucerne, Switzerland1001-50001963Private
Lahore, Punjab, Pakistan11-502016Private
Lahore, Punjab, Pakistan51-2002003Private


Want to Find More Antibiotic Production Companies?

If you want to find more companies that specialize in manufacturing antibiotics and various pharmaceutical products you can do so with Inven. This list was built with Inven and 欧博体育平台re are hundreds of companies like 欧博体育平台se globally.

With Inven you'll also get to know 欧博体育平台 company's:

  • Detailed Ownership: Who owns 欧博体育平台 company? Is it a public or private company? What is 欧博体育平台 ownership structure?
  • Contact data: Who are 欧博体育平台 founders and CEO's? What are 欧博体育平台ir emails and phone numbers?
  • Financials: How do 欧博体育平台se companies perform financially? What are 欧博体育平台ir revenues and profit margins?

...and a lot more!